z-logo
Premium
Micrometastatic adrenal invasion by renal carcinoma in patients undergoing nephrectomy
Author(s) -
Li G .R.,
Soulie M.,
Escourrou G.,
Plante P.,
Pontonnier F.
Publication year - 1996
Publication title -
british journal of urology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.773
H-Index - 148
eISSN - 1464-410X
pISSN - 0007-1331
DOI - 10.1046/j.1464-410x.1996.02633.x
Subject(s) - nephrectomy , medicine , urology , renal carcinoma , renal cell carcinoma , kidney , oncology
Objective  To examine adrenal invasion by renal cell carcinoma (RCC), particularly by adrenal micrometastasis, to determine whether adrenalectomy should be performed during radical nephrectomy. Patients and methods  From 1987 to 1994, 129 patients with RCC (90 men and 39 women, mean age 61.4 years, range 22–81) underwent radical nephrectomy with associated adrenalectomy because they had risk factors for adrenal invasion (tumour size >5 cm, or tumour of the superior pole). Pathological examinations were carried out systematically and records of these examinations reviewed. The tumour size was recorded and the frequency of invasion calculated. Results  There were 10 cases where the gland was invaded; one was a synchronous contralateral metastasis and nine (7%) were ipsilateral invasions of which two were tumours in the superior pole that invaded the gland by direct extension and the other seven invaded the gland by distant metastasis, six being micrometastatic (4.7%). A single micrometastasis was found in two cases (1.5%). There was no adrenal invasion by tumours of <5 cm in diameter from the superior pole. When only tumours >5 cm in diameter were considered, the ipsilateral invasion rate was 11% (9/80) and the micrometastatic rate was 7.5% (6/80). Conclusion  Adrenalectomy need not be performed routinely in small tumours which are detected early, but the possibility of adrenal micrometastasis from larger tumours (>5 cm) should be considered.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here